26 completed, 6 recruiting, 3 unknown, 2 active not recruiting. 41 Phase 2, 6 Phase 1, 2 Phase 3.
Follow Psychological Well-Being: new trials by email Literature Review of Psychological Well-Being trials Research Report on Psychological Well-Being
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Psilocybin for Depression in Veterans Psilocybin, modafinil, zolpidem - Major Depression | Phase 2 | Not yet recruiting | VA Office of Research and Development | 150 | 2027-01-01 | 2026-10-26 |
| Remote Exercise iNtErvention for Wellbeing (RENEW) Trial Qualified exercise professional support, Exercise apps - Exercise Adherence (Primary), Depressive Symptoms (Secondary) | Phase 2 | Not yet recruiting | University of British Columbia | 664 | 2026-11-10 | 2026-11-17 |
| Long-Term Outcomes Following HBOT Hyperbaric Oxygen Therapy (HBOT) - Traumatic Brain Injury, Post-Concussive Symptoms | Phase 2 | Recruiting | Summit Hyperbarics and Wellness | 35 | 2026-06-18 | 2026-07-28 |
| Impact of Smell Testing on Health Outcomes Patient-centered information and education - Olfactory Dysfunction, Wellbeing | Phase 2 | Recruiting | Monell Chemical Senses Center | 1000 | 2026-05-29 | 2026-10-06 |
| Evaluating the Effectiveness of the Common Elements Treatment Approach (CETA) in Peru: Mechanisms of Individual and Intergenerational Change Common Elements Treatment Approach, Enhanced Case Managment - Violence, Parenting | Phase 2 | Recruiting | University of Notre Dame | 600 | 2026-05-18 | 2026-06-25 |
| Sleep Health in U.S. Marines Sleep Leadership, Circadian, Light, and Sleep Skills in Shipboard Military (CLASS-MC) Personnel Program, Insomnia Coach - Depression, Suicidality | Phase 2 | Recruiting | San Diego State University | 860 | 2026-03-31 | 2026-04-16 |
| Mindfulness-Assisted Psychedelic Therapy Psilocybin plus mindfulness training, Psilocybin - Mental Health | Phase 2 | Recruiting | University of Southern California | 40 | 2025-07-30 | 2026-08-06 |
| Impact of a Medical-Financial Partnership Intervention on Parent Mental Health, Perinatal Outcomes, and Child Developmental Risk Medical-Financial Partnership Support - Child Development, Mental Health | Phase 2 | Enrolling by invitation | University of California, Los Angeles | 1200 | 2025-07-07 | 2026-07-22 |
| Novel and Conventional Interventions for Cognitive and Emotional Flexibility in Patient Trauma D-Cycloserine (DCS), Transcranial Magnetic Stimulation, Unified Protocol - Depression, Anxiety | Phase 2 | Active not recruiting | Mclean Hospital | 75 | 2025-06-01 | 2026-10-09 |
| Promoting Active Therapy: Path to Wellness Walk-and-talk therapy - Depression, Anxiety, Physical Activity | Phase 2 | Recruiting | Kansas State University | 60 | 2025-02-28 | 2025-03-05 |
| A Clinical Trial to Assess the Efficacy, Safety, and Tolerability of a Repeat Dose of Fasedienol Nasal Spray for the Acute Treatment of Anxiety in Adults With Social Anxiety Disorder Fasedienol Nasal Spray - Placebo Nasal Spray, Fasedienol Nasal Spray - Fasedienol Nasal Spray, Placebo Nasal Spray - Placebo Nasal Spray - Social Anxiety Disorder | Phase 2 | Completed | VistaGen Therapeutics, Inc. | 61 | 2025-01-09 | 2026-11-04 |
| Pharmacist-led Intervention for Injectable HIV Treatment for Women With Health-related Social Needs Collaborative drug therapy management model, Cabotegravir/Rilpivirine - Hiv | Phase 2 | Active not recruiting | Yale University | 50 | 2024-08-01 | 2026-10-13 |
| Self-Management Program for AIS D SCI SCI Self-Management for AIS D - Psychological Well-Being, Spinal Cord Injuries | Phase 1 / Phase 2 | Withdrawn | VA Office of Research and Development | 2024-05-01 | 2026-03-13 | |
| Cannabinoids as a Treatment for Insomnia in Major Depression 25:1 CBD/THC, 5:1 CBD/THC, Placebo - Insomnia, Depressive Disorder, Major | Phase 2 | Completed | St. Joseph's Healthcare Hamilton | 14 | 2023-08-28 | 2026-01-22 |
| The CANabidiol Use for RElief of Short Term Insomnia 50 mg Cannabidiol (CBD), Placebo, 100 mg Cannabidiol (CBD) - Sleep Disturbance, Insomnia | Phase 2 | Completed | Bod Australia | 208 | 2022-05-01 | 2023-08-16 |
| Oxytocin to Treat PTSD Oxytocin, Placebo - PTSD | Phase 2 | Completed | VA Office of Research and Development | 180 | 2021-01-01 | 2026-03-11 |
| Peer Support Intervention to Mitigate Social Isolation and Stigma of Adolescent Motherhood in Zimbabwe Young Women of Today - Mental Health Disorder, Social Isolation | Phase 2 | Completed | West Chester University of Pennsylvania | 183 | 2018-10-01 | 2022-02-15 |
| Enhancing Delivery of Problem Solving Therapy Using SmartPhone Technology Problem Solving Therapy plus Moving Forward, Problem Solving Therapy - Depression, Anxiety | Phase 1 / Phase 2 | Completed | VA Office of Research and Development | 33 | 2014-04-01 | 2016-11-28 |
| Evaluation of an Intervention to Promote Physical Activity in Outpatients With Mental Disorders Activity Intervention, Healthy Diet Intervention - Mental Disorders | Phase 2 | Completed | Charite University, Berlin, Germany | 86 | 2014-04-01 | 2016-03-10 |
| Testing a Promising Treatment for Youth Substance Abuse in a Community Setting Contingency Management-Family Engagement, Treatment as Usual - Substance Abuse, Delinquency | Phase 1 / Phase 2 | Completed | Medical University of South Carolina | 101 | 2014-04-01 | 2018-07-06 |
Showing 20 of 41. Sign in to see all of them.
Depression (13) · Anxiety Disorders (9) · Stress Disorders, Post-Traumatic (6) · Mental Disorders (5) · Depressive Disorder, Major (3) · Motor Activity (3) · Phobia, Social (3) · Sleep Initiation and Maintenance Disorders (3) · Phobic Disorders (2) · Sleep Wake Disorders (2) · Substance-Related Disorders (2) · Acquired Immunodeficiency Syndrome (1) · Altruism (1) · Anorexia Nervosa (1)
Behavior (41) · Personal Satisfaction (41) · Mental Disorders (21) · Behavioral Symptoms (15) · Nervous System Diseases (6) · Stress Disorders, Traumatic (6) · Trauma and Stressor Related Disorders (6) · Pathological Conditions, Signs and Symptoms (5) · Signs and Symptoms (4) · Social Behavior (4) · Chemically-Induced Disorders (3) · Depressive Disorder (3) · Dyssomnias (3) · Mood Disorders (3) · Neurologic Manifestations (3)
Cognitive Behavioral Therapy (4) · Hypericum extract LI 160 (3) · Psilocybin (2) · (tris(diphenylphosphinomethyl)phenylborate)(p-tolylnitrido)iron(I) (1) · Cannabidiol (1) · Capsules (1) · Cycloserine (1) · Educational Status (1) · Employment, Supported (1) · Escitalopram (1) · Health Promotion (1) · Hyperbaric Oxygenation (1) · Light (1) · Modafinil (1) · Motivational Interviewing (1)
VA Office of Research and Development (5) · National Center for Complementary and Integrative Health (NCCIH) (4) · Arizona State University (1) · Bod Australia (1) · Central Union for the Welfare of the Aged (1) · Charite University, Berlin, Germany (1) · Collinge and Associates, Inc. (1) · Heidelberg University (1) · Kansas State University (1) · Kent State University (1) · Massachusetts General Hospital (1) · Mclean Hospital (1) · Medical University of South Carolina (1) · Monell Chemical Senses Center (1) · Oregon Center for Applied Science, Inc. (1)
United States (29) · Canada (2) · Germany (2) · United Kingdom (2) · Australia (1) · Finland (1) · Peru (1) · Sweden (1)
Kenneth Kobak, PhD (2) · Adam Schickedanz, MD PhD (1) · Amy Birney, MPH, MCHES (1) · Anne Klibanski, MD (1) · Baruch R Cahn, MD, PhD (1) · Benicio N Frey, MD, MSc, PhD (1) · Bert Hayslip, Ph.D. (1) · Chiwoneso Tinago, PhD (1) · Cynthia Price, PhD (1) · Danielle Reed (1) · Eli Puterman, PhD (1) · Elizabeth B Khalil, BSc MSc PhD (Cant.) (1) · Emily Schmied, PhD (1) · Erinne Meenaghan, NP (1)
PMID 18457236, PMID 20815872, PMID 21663696, PMID 23924065, PMID 24251855, PMID 24983382, PMID 27678169, PMID 30188171, PMID 31219558, PMID 32561468, PMID 33393377, PMID 33884617, PMID 36798485, PMID 37957412
I21RX004417 (1), K08MH001662 (1), R01HD115000 (1), R01HD116815 (1), R01MH077596 (1), R01MH083657 (1), R01NR012256 (1), R21MH066131 (1), R21NR011149 (1), R42MH087322 (1), R44DC022498 (1)